For each of these, smelly farts most likely wont be the only symptom
The STEP-1 trial found mean body weight reduction of 14.9% at 68 weeks, but individual response varies based on baseline BMI, dietary structure, and adherence to dose escalation
Separating Science From Marketing Despite its promising biology, GHK-Cu is often marketed with exaggerated claims

Ivacaftor (Trikafta) (CP.PHAR.440) (PDF) Eliglustat (Cerdelga) (CP.PHAR.153) (PDF) Elinzanetant (Lynkuet) (CP.PMN.304) (PDF) Elivaldogene Autotemcel (Skysona) (CP.PHAR.556) (PDF) Elosulfase Alfa (Vimizim) (CP.PHAR.162) (PDF) Elotuzumab (Empliciti) (CP.PHAR.308) (PDF) Elranatamab-bcmm (Elrexfio) (CP.PHAR.652) (PDF) Eltrombopag (Alvaiz, Promacta) (CP.PHAR.180) (PDF) Eluxadoline (Viberzi) (CP.PMN.170) (PDF) Emapalumab-lzsg (Gamifant) (CP.PHAR.402) (PDF) Emicizumab-kxwh (Hemlibra) (CP.PHAR.370) (PDF) Emtricitabine/Tenofovir Alafenamide (Descovy) (CP.PMN.235) (PDF) Enasidenib (Idhifa) (CP.PHAR.363) (PDF) Encorafenib (Braftovi) (CP.PHAR.127) (PDF) Enfortumab Vedotin-ejfv (Padcev) (CP.PHAR.455) (PDF) Enfuvirtide (Fuzeon) (CP.PHAR.41) (PDF) Enoxaparin (Lovenox) (CP.PHAR.224) (PDF) Ensartinib (Ensacove) (CP.PHAR.712) (PDF) Entecavir (Baraclude) (HIM.PA.08) (PDF) Entrectinib (Rozlytrek) (CP.PHAR.441) (PDF) Enzalutamide (Xtandi) (CP.PHAR.106) (PDF) Epcoritamab-bysp (Epkinly) (CP.PHAR.634) (PDF) Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (CP.PCH.55) (PDF) Eplontersen (Wainua) (CP.PHAR.633) (PDF) Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (CP.PHAR.237) (PDF) Epoprostenol (Flolan, Veletri) (CP.PHAR.192) (PDF) Eptinezumab-jjmr (Vyepti) (HIM.PA.SP64) (PDF) Erdafitinib (Balversa) (CP.PHAR.423) (PDF) Erenumab-aooe (Aimovig) (HIM.PA.SP65) (PDF) Eribulin Mesylate (Halaven) (CP.PHAR.318) (PDF) Erlotinib (Tarceva) (CP.PHAR.74) (PDF) Erwinia Asparaginase (Rylaze) (CP.PHAR.301) (PDF) Esketamine (Spravato) (CP.PMN.199) (PDF) Estradiol Vaginal Ring (Femring) (CP.PMN.263) (PDF) Etelcalcetide (Parsabiv) (CP.PHAR.379) (PDF) Eteplirsen (Exondys 51) (CP.PHAR.288) (PDF) Etranacogene Dezaparvovec-drlb (Hemgenix) (CP.PHAR.580) (PDF) Etripamil (Cardamyst) (CP.PMN.306) (PDF) Etuvetidigene Autotemcel (Waskyra) (CP.PHAR.735) (PDF) Everolimus (Afinitor, Afinitor Disperz, Zortress) (CP.PHAR.63) (PDF) Evinacumab-dgnb (Evkeeza) (HIM.PA.166) (PDF) Evolocumab (Repatha) (HIM.PA.156) (PDF) Exagamglogene autotemcel (Casgevy) (CP.PHAR.603) (PDF) Factor IX (Human, Recombinant) (CP.PHAR.218) (PDF) Factor IX Complex, Human (Profilnine) (CP.PHAR.219) (PDF) Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) (PDF) Factor VIII (Human, Recombinant) (CP.PHAR.215) (PDF) Factor VIII/von Willebrand Factor Complex (Human Alphanate, Humate-P, Wilate)
